Cancer
Black Race Predicts Poor Compliance and Higher Prostate Cancer Risk in a Multinational Repeat Biopsy Cohort: Secondary Analysis From the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Clinical Trial.
- Journal
- The Prostate
- Published
- December 31, 2026
- Source
- PubMed / NLM
- Credibility
- 90 / 100
Key takeaway
Research shows Black men are over twice as likely as white men to have aggressive prostate cancer found on a repeat biopsy, even after an initial clear result. However, Black men were less likely to get that follow-up test. This means early tests may miss serious disease, highlighting why continued monitoring is critical for our community.
Why this matters for our communities
Research in cancer helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Cancer
February 1, 2027Dual-modal immunoassay for prostate cancer-derived exosomes enabled by a black phosphorus/silver SERS substrate and Yb/Er co-doped NaGdF4 UCL nanoprobes.Read December 29, 2026Predictors of a Long Hospital Stay After Abdominoperineal Resection of Rectal Cancer: Analysis of the National Cancer Database.Read December 28, 2026Enzyme-responsive 2-dimensional nanomaterials for targeted breast cancer treatment.Read
